From the human brain to the battlefield: MSX Pre-IPO Phase III introduces Neuralink and Anduril, betting on the next frontier of AI
- MSX Maitong will open subscriptions for its Phase 3 Pre-IPO project on August 31, 2026.
- Phase 3 targets include Neuralink and Anduril, representing a shift of AI into the physical world.
- Neuralink focuses on brain-computer interfaces, while Anduril operates in defense technology.
- Previous phases of MSX Pre-IPO have shown significant returns for early investors.
- The validation of liquidity exit paths through public listings and buybacks has been established.
MSX Maitong will open subscriptions for its Phase 3 Pre-IPO project on August 31, 2026. This phase targets two companies, Neuralink and Anduril, which signify a shift of AI from the digital realm into the physical world.
Neuralink, founded by Elon Musk, focuses on brain-computer interfaces, aiming to create a comprehensive system that includes implantable devices and surgical robots. Anduril operates in defense technology, highlighting the diverse applications of AI.
Previous phases of MSX Pre-IPO have demonstrated strong returns for investors, with successful public listings and buybacks validating the investment strategy. The upcoming phase is expected to build on this momentum as it introduces these two significant companies.
从人脑到战场：MSX Pre-IPO第三阶段引入Neuralink和Anduril，押注AI的下一个前沿
MSX Maitong将在2026年8月31日开启其第三阶段Pre-IPO项目的订阅。本阶段的目标是Neuralink和Anduril，这标志着AI从数字领域向物理世界的转变。
Neuralink由埃隆·马斯克创立，专注于脑机接口，旨在创建一个包括可植入设备和外科机器人在内的综合系统。而Anduril则在国防技术领域运营，突显了AI的多样化应用。
MSX Pre-IPO的前几个阶段为投资者展示了强劲的回报，通过成功的公开上市和回购验证了投资策略。即将到来的阶段预计将在此基础上继续发展，引入这两家公司。